<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Clostridioides difficile Infection - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    

    
    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Clostridioides difficile Infection</span>
        </nav>

        <header class="page-header">
            <h1>Clostridioides difficile Infection</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Infectious</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0000705" target="_blank">
                        MONDO:0000705
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Infectious colitis</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Healthcare-associated infections</span>
                
            </div>
            
        </header>

        <!-- Stats bar -->
        <div class="stats-bar">
            <div class="stat-item">
                <div class="stat-value">8</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Genes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Treatments</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Differentials</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
        </div>

        <!-- Classifications -->
        

        <!-- Subtypes -->
        

        <!-- Pathophysiology -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">‚öô</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">8</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Antibiotic-Induced Microbial Depletion</div>
                
                <div class="item-desc">Broad-spectrum antibiotics (especially fluoroquinolones, clindamycin, cephalosporins) cause indiscriminate killing of gut commensals, dramatically reducing microbial diversity and biomass. This creates ecological opportunity for C. difficile colonization.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28613708" target="_blank">PMID:28613708</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The most significant risk factor for C difficile infection is broad-spectrum antibiotics. Patients can be colonized with C difficile without symptoms, but antibiotic use disturbs the balance of gut flora, enabling C difficile overgrowth and infection."</div>
                
                
                <div class="evidence-explanation">StatPearls notes antibiotic-driven dysbiosis allows C. difficile overgrowth in the colon.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Loss of Colonization Resistance</div>
                
                <div class="item-desc">The healthy microbiome normally prevents C. difficile colonization through multiple mechanisms: nutrient competition (especially for proline, amino acids), niche exclusion, and production of bacteriocins and antimicrobial peptides. Antibiotic disruption removes these competitive barriers.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26185088" target="_blank">PMID:26185088</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A general feature of a normal, healthy gut microbiota can generate conditions in the gut that disfavor colonization of enteric pathogens. This is termed colonization-resistance (CR). Upon disturbance of the microbiota, CR can be transiently disrupted, and pathogens can gain the opportunity to..."</div>
                
                
                <div class="evidence-explanation">Review describes colonization resistance as a key protective function lost during antibiotic-induced dysbiosis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40366862" target="_blank">PMID:40366862</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The gut microbiota in the Control group showed higher Chao1 index (p &lt; 0.05)... Collinsella_aerofaciens, Collinsella_sp_4_8_47FAA, Collinsella_tanakaei and Collinsella_sp_CAG_166 were enriched in Control."</div>
                
                
                <div class="evidence-explanation">Metagenomic study confirms CDI patients have reduced diversity and depletion of protective Collinsella species compared to healthy controls.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Loss of Secondary Bile Acid Production</div>
                
                <div class="item-desc">Loss of bile acid 7Œ±-dehydroxylating bacteria (Clostridium scindens, C. hylemonae, and related taxa) prevents conversion of primary bile acids (cholate, chenodeoxycholate) to secondary bile acids (deoxycholate, lithocholate). Primary bile acids promote C. difficile spore germination; secondary bile acids inhibit both germination and vegetative growth.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32179626" target="_blank">PMID:32179626</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Inhibition of C. difficile by commensals correlated with the efficient conversion of cholate to deoxycholate, a secondary bile acid that inhibits C. difficile germination, growth, and toxin production."</div>
                
                
                <div class="evidence-explanation">Study shows bile acid conversion by bai operon-carrying bacteria is key to C. difficile inhibition.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28066726" target="_blank">PMID:28066726</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Amendment of Oligo-MM12 with C. scindens normalized the large intestinal bile acid composition by reconstituting 7Œ±-dehydroxylation. These changes had only minor effects on the composition of the native Oligo-MM12, but significantly decreased early large intestinal C. difficile colonization and..."</div>
                
                
                <div class="evidence-explanation">Gnotobiotic mouse study demonstrates C. scindens provides colonization resistance through bile acid metabolism.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">C. difficile Germination and Expansion</div>
                
                <div class="item-desc">C. difficile spores germinate in the favorable environment created by antibiotic disruption: available nutrients (especially proline), primary bile acids, and lack of competition. Vegetative cells proliferate to high density, occupying the ecological niche vacated by commensals.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28613708" target="_blank">PMID:28613708</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Patients can be colonized with C difficile without symptoms, but antibiotic use disturbs the balance of gut flora, enabling C difficile overgrowth and infection."</div>
                
                
                <div class="evidence-explanation">Antibiotic-disrupted environment permits C. difficile overgrowth from spore to vegetative form.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Toxin Production (TcdA/TcdB)</div>
                
                <div class="item-desc">C. difficile secretes two large clostridial glucosylating toxins: TcdA (enterotoxin, 308 kDa) and TcdB (cytotoxin, 270 kDa). Both are glucosyltransferases that inactivate Rho family GTPases (Rho, Rac, Cdc42) by monoglucosylation of a critical threonine residue, disrupting the actin cytoskeleton.
</div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Pathogenesis
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0009405" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15831824" target="_blank">PMID:15831824</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Following expression and release from the bacterium, TcdA and TcdB translocate to the cytosol of target cells and inactivate small GTP-binding proteins, which include Rho, Rac, and Cdc42. Inactivation of these substrates occurs through monoglucosylation of a single reactive threonine."</div>
                
                
                <div class="evidence-explanation">Comprehensive review details the molecular mechanism of toxin action on Rho GTPases.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34837014" target="_blank">PMID:34837014</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The bacterium produces up to three toxins, which are considered the major virulence factors in C. difficile infection. These toxins promote inflammation, tissue damage and diarrhoea."</div>
                
                
                <div class="evidence-explanation">Review confirms toxins as major virulence factors causing disease pathology.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Epithelial Cell Death and Barrier Disruption</div>
                
                <div class="item-desc">Toxin-mediated Rho GTPase inactivation causes actin cytoskeleton condensation, loss of cell-cell junctions, and epithelial cell rounding followed by death. This creates gaps in the epithelial barrier, exposing the lamina propria to luminal contents.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Colonic Epithelial Cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0011108" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15831824" target="_blank">PMID:15831824</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"By glucosylating small GTPases, TcdA and TcdB cause actin condensation and cell rounding, which is followed by death of the cell."</div>
                
                
                <div class="evidence-explanation">Review describes the cellular consequences of toxin-mediated GTPase inactivation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Neutrophil Recruitment and Inflammation</div>
                
                <div class="item-desc">TcdA triggers IL-8 and other chemokine release from epithelial cells, causing massive neutrophil influx into the colonic mucosa. Neutrophils form the characteristic &#34;volcano lesions&#34; and contribute to tissue damage through degranulation, reactive oxygen species, and NET formation.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Neutrophil
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000775" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Inflammatory Response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006954" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15831824" target="_blank">PMID:15831824</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Furthermore, there have been major advances in defining the role of these toxins in modulating the inflammatory events involving the disruption of cell junctions, neuronal activation, cytokine production, and infiltration by polymorphonuclear cells."</div>
                
                
                <div class="evidence-explanation">Review details toxin-induced inflammatory cascade including neutrophil recruitment.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Pseudomembranous Colitis</div>
                
                <div class="item-desc">Characteristic raised yellow-white plaques on colonic mucosa composed of fibrin, mucus, neutrophils, and cellular debris overlying areas of epithelial necrosis. Represents severe C. difficile infection with high morbidity. Fluid secretion and diarrhea result from barrier loss and inflammation.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34837014" target="_blank">PMID:34837014</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"These toxins promote inflammation, tissue damage and diarrhoea."</div>
                
                
                <div class="evidence-explanation">Toxin activity drives the pseudomembrane-associated inflammation and diarrheal fluid loss that characterize severe CDI.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">‚¨°</div>
                <h2 class="card-title">Causal Graph</h2>
            </div>
            
            <div class="mermaid-container">
                <pre class="mermaid">graph TD
    Epithelial_Cell_Death_and_Barrier_Disruption[&#34;Epithelial Cell Death and Barrier Disruption&#34;]
    C._difficile_Germination_and_Expansion[&#34;C. difficile Germination and Expansion&#34;]
    Pseudomembranous_Colitis[&#34;Pseudomembranous Colitis&#34;]
    Toxin_Production_TcdA_TcdB[&#34;Toxin Production (TcdA/TcdB)&#34;]
    Loss_of_Colonization_Resistance[&#34;Loss of Colonization Resistance&#34;]
    Loss_of_Secondary_Bile_Acid_Production[&#34;Loss of Secondary Bile Acid Production&#34;]
    Antibiotic_Induced_Microbial_Depletion[&#34;Antibiotic-Induced Microbial Depletion&#34;]
    Neutrophil_Recruitment_and_Inflammation[&#34;Neutrophil Recruitment and Inflammation&#34;]

    Antibiotic_Induced_Microbial_Depletion --&gt; Loss_of_Colonization_Resistance
    Antibiotic_Induced_Microbial_Depletion --&gt; Loss_of_Secondary_Bile_Acid_Production
    Loss_of_Colonization_Resistance --&gt; C._difficile_Germination_and_Expansion
    Loss_of_Secondary_Bile_Acid_Production --&gt; C._difficile_Germination_and_Expansion
    C._difficile_Germination_and_Expansion --&gt; Toxin_Production_TcdA_TcdB
    Toxin_Production_TcdA_TcdB --&gt; Epithelial_Cell_Death_and_Barrier_Disruption
    Toxin_Production_TcdA_TcdB --&gt; Neutrophil_Recruitment_and_Inflammation
    Epithelial_Cell_Death_and_Barrier_Disruption --&gt; Pseudomembranous_Colitis
    Neutrophil_Recruitment_and_Inflammation --&gt; Pseudomembranous_Colitis

    style Epithelial_Cell_Death_and_Barrier_Disruption fill:#dbeafe
    style C._difficile_Germination_and_Expansion fill:#dbeafe
    style Pseudomembranous_Colitis fill:#dbeafe
    style Toxin_Production_TcdA_TcdB fill:#dbeafe
    style Loss_of_Colonization_Resistance fill:#dbeafe
    style Loss_of_Secondary_Bile_Acid_Production fill:#dbeafe
    style Antibiotic_Induced_Microbial_Depletion fill:#dbeafe
    style Neutrophil_Recruitment_and_Inflammation fill:#dbeafe</pre>
            </div>
        </div>
        

        <!-- Phenotypes -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">‚óè</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Diarrhea
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0002014" target="_blank">
                            HP:0002014
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28613708" target="_blank">PMID:28613708</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"This obligate anaerobic bacillus is recognized for its ability to produce toxins and is the leading cause of antibiotic-associated diarrhea worldwide."</div>
                
                
                <div class="evidence-explanation">StatPearls review states CDI is the leading cause of antibiotic-associated diarrhea.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Abdominal pain
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0002027" target="_blank">
                            HP:0002027
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37004449" target="_blank">PMID:37004449</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A 40 years old male patient presented with abdominal pain and diarrhea of 10 days duration after he was diagnosed and managed as a case of Clostridium Difficile infection and amebiasis."</div>
                
                
                <div class="evidence-explanation">Case report notes abdominal pain with CDI presentation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Fever
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0001945" target="_blank">
                            HP:0001945
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33402156" target="_blank">PMID:33402156</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A 53-year-old Caucasian male presented to the emergency room for two days of lower abdominal pain associated with nausea, non-bilious vomiting, and subjective fevers."</div>
                
                
                <div class="evidence-explanation">CDI case report documents fever accompanying infection.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Genetic Associations -->
        

        <!-- Treatments -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">üíä</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Vancomycin
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Oral vancomycin is first-line treatment for C. difficile infection.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38508330" target="_blank">PMID:38508330</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Effective infection management requires appropriate interpretation of diagnostic tests, as well as the use of vancomycin and fidaxomicin as first-line treatment."</div>
                
                
                <div class="evidence-explanation">Clinical review lists oral vancomycin among first-line agents for CDI management.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Fidaxomicin
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Alternative antibiotic with lower recurrence rates.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38726585" target="_blank">PMID:38726585</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"IDSA/SHEA shifted its preference for initial treatment to fidaxomicin over vancomycin and metronidazole due to its lower recurrence rate."</div>
                
                
                <div class="evidence-explanation">Guideline update highlights fidaxomicin as preferred initial therapy because of reduced recurrence.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39282548" target="_blank">PMID:39282548</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Management of CDI has evolved, with fidaxomicin emerging as a superior treatment option over vancomycin for initial and recurrent infections due to its reduction of recurrence rate."</div>
                
                
                <div class="evidence-explanation">Recent review reinforces fidaxomicin&#39;s superiority to vancomycin for initial and recurrent CDI.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Fecal microbiota transplantation
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000748" target="_blank">
                            MAXO:0000748
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Restoration of normal gut microbiota for recurrent infections.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38508330" target="_blank">PMID:38508330</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Novel treatments such as Bezlotoxumab, fecal microbiota transplant, and live biotherapeutic products are proven effective in recurrent C. difficile infection and address dysbiosis."</div>
                
                
                <div class="evidence-explanation">Review notes FMT as effective for recurrent CDI in restoring microbiota.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39282548" target="_blank">PMID:39282548</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Faecal microbiota transplantation (FMT) is effective for recurrent CDI, restoring gut eubiosis."</div>
                
                
                <div class="evidence-explanation">Update article explicitly states FMT effectiveness for recurrent CDI by reestablishing gut balance.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Bezlotoxumab
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Monoclonal antibody against toxin B to prevent CDI recurrence when added to standard therapy.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39282548" target="_blank">PMID:39282548</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Bezlotoxumab, a monoclonal antibody against C. difficile toxin B, has shown promise in reducing recurrence rates."</div>
                
                
                <div class="evidence-explanation">Review notes bezlotoxumab reduces CDI recurrence when used adjunctively with standard antibiotics.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Loop ileostomy with colonic lavage
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000004" target="_blank">
                            MAXO:0000004
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Organ-preserving surgical approach for fulminant CDI when medical therapy fails.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39650985" target="_blank">PMID:39650985</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"In cases where pharmacological management has been ineffective, fecal microbiota transplantation and surgical intervention demonstrated success."</div>
                
                
                <div class="evidence-explanation">Case report highlights loop ileostomy with lavage as a surgical option after failed pharmacologic therapy in fulminant CDI.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">üåç</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Healthcare facility exposure</div>
                
                
                <div class="item-desc">Hospital environments facilitate C. difficile spore persistence and transmission, underpinning healthcare-associated CDI.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28613708" target="_blank">PMID:28613708</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Contaminated surfaces and medical equipment in healthcare facilities can become reservoirs for C difficile spores, potentially transmitting to patients if proper cleaning protocols are not routinely implemented."</div>
                
                
                <div class="evidence-explanation">Review notes hospital environmental reservoirs drive healthcare-associated CDI transmission.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        

        <!-- Differential Diagnoses -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef2f2; color: #dc2626;">üîÄ</div>
                <h2 class="card-title">Differential Diagnoses</h2>
                <span class="card-count">5</span>
            </div>
            <p style="margin-bottom: 16px; font-size: 0.95rem; color: var(--text-muted);">
                Conditions with similar clinical presentations that must be differentiated from Clostridioides difficile Infection:
            </p>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Ulcerative colitis
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0005101" target="_blank">
                            MONDO:0005101
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Chronic immune-mediated colitis that can flare with bloody diarrhea and may coexist with CDI.
                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Continuous colonic inflammation from rectum proximally on endoscopy.</li>
                        
                        <li>Bloody mucus stools and chronic course with flares.</li>
                        
                        <li>Histology shows crypt architectural distortion and chronic inflammatory infiltrate.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38335423" target="_blank">PMID:38335423</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"This case underscores the diagnosis of severe UC through colonoscopy and colonic biopsy, along with the supplementary identification of a positive result for Clostridioides difficile in the fecal sample."</div>
                
                
                <div class="evidence-explanation">Report highlights overlapping presentation of UC flare with concurrent CDI.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Lymphocytic colitis
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0000704" target="_blank">
                            MONDO:0000704
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Microscopic colitis subtype causing chronic watery diarrhea that can mimic or coexist with CDI.
                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Chronic watery diarrhea with normal endoscopic appearance.</li>
                        
                        <li>Biopsy reveals increased intraepithelial lymphocytes without ulceration.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38313897" target="_blank">PMID:38313897</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Persistent watery diarrhea and was diagnosed with lymphocytic colitis in the setting of a concomitant C. difficile infection."</div>
                
                
                <div class="evidence-explanation">Case shows lymphocytic colitis presenting with CDI-like diarrhea.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Ischemic colitis
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0000701" target="_blank">
                            MONDO:0000701
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Colonic ischemia presenting with acute abdominal pain and diarrhea that can be confused with infectious colitis.
                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Sudden crampy abdominal pain with segmental ischemic changes on imaging/endoscopy.</li>
                        
                        <li>Often hematochezia and disproportionate pain relative to diarrhea volume.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37004449" target="_blank">PMID:37004449</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A 40 years old male patient presented with abdominal pain and diarrhea of 10 days duration after he was diagnosed and managed as a case of Clostridium Difficile infection and amebiasis; computed tomography angiography revealed a vascular malformation ... he underwent Hartmann&#39;s procedure due to..."</div>
                
                
                <div class="evidence-explanation">Case documents ischemic colitis occurring in the context of CDI symptoms.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Strongyloidiasis hyperinfection
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0005974" target="_blank">
                            MONDO:0005974
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Parasitic hyperinfection that can present with diarrhea and mimic severe CDI in immunosuppressed hosts.
                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Occurs in immunosuppressed patients (e.g., prolonged steroids) with disseminated larvae.</li>
                        
                        <li>Larvae detectable in stool, sputum, or bronchoalveolar lavage; eosinophilia may be absent.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35181536" target="_blank">PMID:35181536</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"We describe a fatal case of S. stercoralis hyperinfection ... presenting with diarrhea along with Clostridium difficile colitis after the use of a prolonged course of steroids."</div>
                
                
                <div class="evidence-explanation">Report shows Strongyloides hyperinfection mimicking CDI in steroid-treated patient.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Acute appendicitis
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0005649" target="_blank">
                            MONDO:0005649
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Extraintestinal manifestation with right lower quadrant pain that can coexist with or be mistaken for CDI.
                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Localized right lower quadrant tenderness with rebound/guarding.</li>
                        
                        <li>CT shows appendiceal enlargement and wall thickening; diarrhea often absent or minimal.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33402156" target="_blank">PMID:33402156</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Repeat CT of the abdomen and pelvis with contrast (Fig. 1) was performed which showed progression of his colitis, now extending from the cecum to the rectum as well as findings concerning for appendicitis as seen on the prior CT scan. C. difficile testing was positive for which the patient was..."</div>
                
                
                <div class="evidence-explanation">Case report documents appendicitis identified alongside CDI with CT progression guiding management.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Clostridioides difficile Infection
category: Infectious
disease_term:
  preferred_term: Clostridium difficile colitis
  term:
    id: MONDO:0000705
    label: Clostridium difficile colitis
parents:
  - Infectious colitis
  - Healthcare-associated infections
infectious_agent:
  - name: Clostridioides difficile
    infectious_agent_term:
      preferred_term: Clostridioides difficile
      term:
        id: NCBITaxon:1496
        label: Clostridioides difficile
pathophysiology:
  - name: Antibiotic-Induced Microbial Depletion
    description: &gt;
      Broad-spectrum antibiotics (especially fluoroquinolones, clindamycin,
      cephalosporins) cause indiscriminate killing of gut commensals, dramatically
      reducing microbial diversity and biomass. This creates ecological opportunity
      for C. difficile colonization.
    locations:
      - preferred_term: colon
        term:
          id: UBERON:0001155
          label: colon
    downstream:
      - target: Loss of Colonization Resistance
        description: Depleted microbiota cannot compete with C. difficile
      - target: Loss of Secondary Bile Acid Production
        description: Depletion of bile acid 7Œ±-dehydroxylating bacteria
    evidence:
      - reference: PMID:28613708
        supports: SUPPORT
        snippet: &#34;The most significant risk factor for C difficile infection is broad-spectrum antibiotics. Patients can be colonized with C difficile without symptoms, but antibiotic use disturbs the balance of gut flora, enabling C difficile overgrowth and infection.&#34;
        explanation: StatPearls notes antibiotic-driven dysbiosis allows C. difficile overgrowth in the colon.

  - name: Loss of Colonization Resistance
    description: &gt;
      The healthy microbiome normally prevents C. difficile colonization through
      multiple mechanisms: nutrient competition (especially for proline, amino acids),
      niche exclusion, and production of bacteriocins and antimicrobial peptides.
      Antibiotic disruption removes these competitive barriers.
    notes: &gt;
      Metagenomics studies consistently show CDI patients have depleted Lachnospiraceae,
      Ruminococcaceae, and Collinsella spp. compared to controls. BugSigDB signatures
      for CDI-related studies confirm depletion of these protective taxa. The Lachnospiraceae
      member C. scindens is particularly important for bile acid-mediated resistance.
    downstream:
      - target: C. difficile Germination and Expansion
        description: Without competitive exclusion, C. diff spores germinate and vegetative cells proliferate
    evidence:
      - reference: PMID:26185088
        supports: SUPPORT
        snippet: &#34;A general feature of a normal, healthy gut microbiota can generate conditions in the gut that disfavor colonization of enteric pathogens. This is termed colonization-resistance (CR). Upon disturbance of the microbiota, CR can be transiently disrupted, and pathogens can gain the opportunity to grow to high levels.&#34;
        explanation: Review describes colonization resistance as a key protective function lost during antibiotic-induced dysbiosis.
      - reference: PMID:40366862
        supports: SUPPORT
        snippet: &#34;The gut microbiota in the Control group showed higher Chao1 index (p &lt; 0.05)... Collinsella_aerofaciens, Collinsella_sp_4_8_47FAA, Collinsella_tanakaei and Collinsella_sp_CAG_166 were enriched in Control.&#34;
        explanation: Metagenomic study confirms CDI patients have reduced diversity and depletion of protective Collinsella species compared to healthy controls.

  - name: Loss of Secondary Bile Acid Production
    description: &gt;
      Loss of bile acid 7Œ±-dehydroxylating bacteria (Clostridium scindens,
      C. hylemonae, and related taxa) prevents conversion of primary bile acids
      (cholate, chenodeoxycholate) to secondary bile acids (deoxycholate,
      lithocholate). Primary bile acids promote C. difficile spore germination;
      secondary bile acids inhibit both germination and vegetative growth.
    notes: &gt;
      The bai (bile acid-inducible) operon encodes the 7Œ±-dehydroxylation pathway.
      ~2mM deoxycholate is sufficient to inhibit C. difficile growth in vitro.
    downstream:
      - target: C. difficile Germination and Expansion
        description: Elevated primary bile acids and depleted secondary bile acids favor spore germination
    evidence:
      - reference: PMID:32179626
        supports: SUPPORT
        snippet: &#34;Inhibition of C. difficile by commensals correlated with the efficient conversion of cholate to deoxycholate, a secondary bile acid that inhibits C. difficile germination, growth, and toxin production.&#34;
        explanation: Study shows bile acid conversion by bai operon-carrying bacteria is key to C. difficile inhibition.
      - reference: PMID:28066726
        supports: SUPPORT
        snippet: &#34;Amendment of Oligo-MM12 with C. scindens normalized the large intestinal bile acid composition by reconstituting 7Œ±-dehydroxylation. These changes had only minor effects on the composition of the native Oligo-MM12, but significantly decreased early large intestinal C. difficile colonization and pathogenesis.&#34;
        explanation: Gnotobiotic mouse study demonstrates C. scindens provides colonization resistance through bile acid metabolism.

  - name: C. difficile Germination and Expansion
    description: &gt;
      C. difficile spores germinate in the favorable environment created by
      antibiotic disruption: available nutrients (especially proline), primary
      bile acids, and lack of competition. Vegetative cells proliferate to high
      density, occupying the ecological niche vacated by commensals.
    downstream:
      - target: Toxin Production (TcdA/TcdB)
        description: Vegetative C. difficile produces toxins A and B during stationary phase
    evidence:
      - reference: PMID:28613708
        supports: SUPPORT
        snippet: &#34;Patients can be colonized with C difficile without symptoms, but antibiotic use disturbs the balance of gut flora, enabling C difficile overgrowth and infection.&#34;
        explanation: Antibiotic-disrupted environment permits C. difficile overgrowth from spore to vegetative form.

  - name: Toxin Production (TcdA/TcdB)
    description: &gt;
      C. difficile secretes two large clostridial glucosylating toxins: TcdA
      (enterotoxin, 308 kDa) and TcdB (cytotoxin, 270 kDa). Both are
      glucosyltransferases that inactivate Rho family GTPases (Rho, Rac, Cdc42)
      by monoglucosylation of a critical threonine residue, disrupting the
      actin cytoskeleton.
    biological_processes:
      - preferred_term: Pathogenesis
        term:
          id: GO:0009405
          label: pathogenesis
    downstream:
      - target: Epithelial Cell Death and Barrier Disruption
        description: Toxins cause cytoskeletal collapse and cell death
      - target: Neutrophil Recruitment and Inflammation
        description: Toxins trigger IL-8 release and massive neutrophil influx
    evidence:
      - reference: PMID:15831824
        supports: SUPPORT
        snippet: &#34;Following expression and release from the bacterium, TcdA and TcdB translocate to the cytosol of target cells and inactivate small GTP-binding proteins, which include Rho, Rac, and Cdc42. Inactivation of these substrates occurs through monoglucosylation of a single reactive threonine.&#34;
        explanation: Comprehensive review details the molecular mechanism of toxin action on Rho GTPases.
      - reference: PMID:34837014
        supports: SUPPORT
        snippet: &#34;The bacterium produces up to three toxins, which are considered the major virulence factors in C. difficile infection. These toxins promote inflammation, tissue damage and diarrhoea.&#34;
        explanation: Review confirms toxins as major virulence factors causing disease pathology.

  - name: Epithelial Cell Death and Barrier Disruption
    description: &gt;
      Toxin-mediated Rho GTPase inactivation causes actin cytoskeleton
      condensation, loss of cell-cell junctions, and epithelial cell rounding
      followed by death. This creates gaps in the epithelial barrier, exposing
      the lamina propria to luminal contents.
    cell_types:
      - preferred_term: Colonic Epithelial Cell
        term:
          id: CL:0011108
          label: colon epithelial cell
    downstream:
      - target: Pseudomembranous Colitis
        description: Epithelial destruction with inflammatory exudate forms pseudomembranes
    evidence:
      - reference: PMID:15831824
        supports: SUPPORT
        snippet: &#34;By glucosylating small GTPases, TcdA and TcdB cause actin condensation and cell rounding, which is followed by death of the cell.&#34;
        explanation: Review describes the cellular consequences of toxin-mediated GTPase inactivation.

  - name: Neutrophil Recruitment and Inflammation
    description: &gt;
      TcdA triggers IL-8 and other chemokine release from epithelial cells,
      causing massive neutrophil influx into the colonic mucosa. Neutrophils
      form the characteristic &#34;volcano lesions&#34; and contribute to tissue damage
      through degranulation, reactive oxygen species, and NET formation.
    cell_types:
      - preferred_term: Neutrophil
        term:
          id: CL:0000775
          label: neutrophil
    biological_processes:
      - preferred_term: Inflammatory Response
        term:
          id: GO:0006954
          label: inflammatory response
    downstream:
      - target: Pseudomembranous Colitis
        description: Neutrophils form the inflammatory core of pseudomembranes
    evidence:
      - reference: PMID:15831824
        supports: SUPPORT
        snippet: &#34;Furthermore, there have been major advances in defining the role of these toxins in modulating the inflammatory events involving the disruption of cell junctions, neuronal activation, cytokine production, and infiltration by polymorphonuclear cells.&#34;
        explanation: Review details toxin-induced inflammatory cascade including neutrophil recruitment.

  - name: Pseudomembranous Colitis
    description: &gt;
      Characteristic raised yellow-white plaques on colonic mucosa composed of
      fibrin, mucus, neutrophils, and cellular debris overlying areas of
      epithelial necrosis. Represents severe C. difficile infection with high
      morbidity. Fluid secretion and diarrhea result from barrier loss and
      inflammation.
    locations:
      - preferred_term: colon
        term:
          id: UBERON:0001155
          label: colon
    evidence:
      - reference: PMID:34837014
        supports: SUPPORT
        snippet: &#34;These toxins promote inflammation, tissue damage and diarrhoea.&#34;
        explanation: Toxin activity drives the pseudomembrane-associated inflammation and diarrheal fluid loss that characterize severe CDI.
phenotypes:
  - name: Diarrhea
    description: Watery diarrhea, often foul-smelling, is the hallmark symptom.
    phenotype_term:
      preferred_term: Diarrhea
      term:
        id: HP:0002014
        label: Diarrhea
    evidence:
      - reference: PMID:28613708
        supports: SUPPORT
        snippet: This obligate anaerobic bacillus is recognized for its ability to produce toxins and is the leading cause of antibiotic-associated diarrhea worldwide.
        explanation: StatPearls review states CDI is the leading cause of antibiotic-associated diarrhea.
  - name: Abdominal pain
    description: Cramping abdominal pain accompanying diarrhea.
    phenotype_term:
      preferred_term: Abdominal pain
      term:
        id: HP:0002027
        label: Abdominal pain
    evidence:
      - reference: PMID:37004449
        supports: SUPPORT
        snippet: A 40 years old male patient presented with abdominal pain and diarrhea of 10 days duration after he was diagnosed and managed as a case of Clostridium Difficile infection and amebiasis.
        explanation: Case report notes abdominal pain with CDI presentation.
  - name: Fever
    description: Systemic inflammatory response to infection.
    phenotype_term:
      preferred_term: Fever
      term:
        id: HP:0001945
        label: Fever
    evidence:
      - reference: PMID:33402156
        supports: SUPPORT
        snippet: A 53-year-old Caucasian male presented to the emergency room for two days of lower abdominal pain associated with nausea, non-bilious vomiting, and subjective fevers.
        explanation: CDI case report documents fever accompanying infection.
treatments:
  - name: Vancomycin
    description: Oral vancomycin is first-line treatment for C. difficile infection.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
      qualifiers:
        - predicate:
            preferred_term: route of administration
            term:
              id: NCIT:C38114
              label: Route of Administration
          value:
            preferred_term: oral route of administration
            term:
              id: NCIT:C38288
              label: Oral Route of Administration
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: vancomycin
            term:
              id: NCIT:C288
              label: vancomycin
    evidence:
      - reference: PMID:38508330
        supports: SUPPORT
        snippet: Effective infection management requires appropriate interpretation of diagnostic tests, as well as the use of vancomycin and fidaxomicin as first-line treatment.
        explanation: Clinical review lists oral vancomycin among first-line agents for CDI management.
  - name: Fidaxomicin
    description: Alternative antibiotic with lower recurrence rates.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
      qualifiers:
        - predicate:
            preferred_term: route of administration
            term:
              id: NCIT:C38114
              label: Route of Administration
          value:
            preferred_term: oral route of administration
            term:
              id: NCIT:C38288
              label: Oral Route of Administration
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: fidaxomicin
            term:
              id: NCIT:C95509
              label: fidaxomicin
    evidence:
      - reference: PMID:38726585
        supports: SUPPORT
        snippet: IDSA/SHEA shifted its preference for initial treatment to fidaxomicin over vancomycin and metronidazole due to its lower recurrence rate.
        explanation: Guideline update highlights fidaxomicin as preferred initial therapy because of reduced recurrence.
      - reference: PMID:39282548
        supports: SUPPORT
        snippet: Management of CDI has evolved, with fidaxomicin emerging as a superior treatment option over vancomycin for initial and recurrent infections due to its reduction of recurrence rate.
        explanation: Recent review reinforces fidaxomicin&#39;s superiority to vancomycin for initial and recurrent CDI.
  - name: Fecal microbiota transplantation
    description: Restoration of normal gut microbiota for recurrent infections.
    treatment_term:
      preferred_term: fecal microbiota transplantation
      term:
        id: MAXO:0000748
        label: fecal microbiota transplantation
      qualifiers:
        - predicate:
            preferred_term: clinical course
            term:
              id: NCIT:C28008
              label: Clinical Course
          value:
            preferred_term: recurrent disease
            term:
              id: MONDO:0700096
              label: recurrent disease
    evidence:
      - reference: PMID:38508330
        supports: SUPPORT
        snippet: Novel treatments such as Bezlotoxumab, fecal microbiota transplant, and live biotherapeutic products are proven effective in recurrent C. difficile infection and address dysbiosis.
        explanation: Review notes FMT as effective for recurrent CDI in restoring microbiota.
      - reference: PMID:39282548
        supports: SUPPORT
        snippet: Faecal microbiota transplantation (FMT) is effective for recurrent CDI, restoring gut eubiosis.
        explanation: Update article explicitly states FMT effectiveness for recurrent CDI by reestablishing gut balance.
  - name: Bezlotoxumab
    description: Monoclonal antibody against toxin B to prevent CDI recurrence when added to standard therapy.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
      qualifiers:
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: bezlotoxumab
            term:
              id: NCIT:C121379
              label: Bezlotoxumab
    evidence:
      - reference: PMID:39282548
        supports: SUPPORT
        snippet: Bezlotoxumab, a monoclonal antibody against C. difficile toxin B, has shown promise in reducing recurrence rates.
        explanation: Review notes bezlotoxumab reduces CDI recurrence when used adjunctively with standard antibiotics.
  - name: Loop ileostomy with colonic lavage
    description: Organ-preserving surgical approach for fulminant CDI when medical therapy fails.
    treatment_term:
      preferred_term: surgical procedure
      term:
        id: MAXO:0000004
        label: surgical procedure
    evidence:
      - reference: PMID:39650985
        supports: SUPPORT
        snippet: In cases where pharmacological management has been ineffective, fecal microbiota transplantation and surgical intervention demonstrated success.
        explanation: Case report highlights loop ileostomy with lavage as a surgical option after failed pharmacologic therapy in fulminant CDI.
differential_diagnoses:
  - name: Ulcerative colitis
    description: Chronic immune-mediated colitis that can flare with bloody diarrhea and may coexist with CDI.
    distinguishing_features:
      - Continuous colonic inflammation from rectum proximally on endoscopy.
      - Bloody mucus stools and chronic course with flares.
      - Histology shows crypt architectural distortion and chronic inflammatory infiltrate.
    disease_term:
      preferred_term: ulcerative colitis
      term:
        id: MONDO:0005101
        label: ulcerative colitis
    evidence:
      - reference: PMID:38335423
        supports: SUPPORT
        snippet: This case underscores the diagnosis of severe UC through colonoscopy and colonic biopsy, along with the supplementary identification of a positive result for Clostridioides difficile in the fecal sample.
        explanation: Report highlights overlapping presentation of UC flare with concurrent CDI.
  - name: Lymphocytic colitis
    description: Microscopic colitis subtype causing chronic watery diarrhea that can mimic or coexist with CDI.
    distinguishing_features:
      - Chronic watery diarrhea with normal endoscopic appearance.
      - Biopsy reveals increased intraepithelial lymphocytes without ulceration.
    disease_term:
      preferred_term: lymphocytic colitis
      term:
        id: MONDO:0000704
        label: lymphocytic colitis
    evidence:
      - reference: PMID:38313897
        supports: SUPPORT
        snippet: Persistent watery diarrhea and was diagnosed with lymphocytic colitis in the setting of a concomitant C. difficile infection.
        explanation: Case shows lymphocytic colitis presenting with CDI-like diarrhea.
  - name: Ischemic colitis
    description: Colonic ischemia presenting with acute abdominal pain and diarrhea that can be confused with infectious colitis.
    distinguishing_features:
      - Sudden crampy abdominal pain with segmental ischemic changes on imaging/endoscopy.
      - Often hematochezia and disproportionate pain relative to diarrhea volume.
    disease_term:
      preferred_term: ischemic colitis
      term:
        id: MONDO:0000701
        label: ischemic colitis
    evidence:
      - reference: PMID:37004449
        supports: SUPPORT
        snippet: A 40 years old male patient presented with abdominal pain and diarrhea of 10 days duration after he was diagnosed and managed as a case of Clostridium Difficile infection and amebiasis; computed tomography angiography revealed a vascular malformation ... he underwent Hartmann&#39;s procedure due to colonic ischemia.
        explanation: Case documents ischemic colitis occurring in the context of CDI symptoms.
  - name: Strongyloidiasis hyperinfection
    description: Parasitic hyperinfection that can present with diarrhea and mimic severe CDI in immunosuppressed hosts.
    distinguishing_features:
      - Occurs in immunosuppressed patients (e.g., prolonged steroids) with disseminated larvae.
      - Larvae detectable in stool, sputum, or bronchoalveolar lavage; eosinophilia may be absent.
    disease_term:
      preferred_term: strongyloidiasis
      term:
        id: MONDO:0005974
        label: strongyloidiasis
    evidence:
      - reference: PMID:35181536
        supports: SUPPORT
        snippet: We describe a fatal case of S. stercoralis hyperinfection ... presenting with diarrhea along with Clostridium difficile colitis after the use of a prolonged course of steroids.
        explanation: Report shows Strongyloides hyperinfection mimicking CDI in steroid-treated patient.
  - name: Acute appendicitis
    description: Extraintestinal manifestation with right lower quadrant pain that can coexist with or be mistaken for CDI.
    distinguishing_features:
      - Localized right lower quadrant tenderness with rebound/guarding.
      - CT shows appendiceal enlargement and wall thickening; diarrhea often absent or minimal.
    disease_term:
      preferred_term: appendicitis
      term:
        id: MONDO:0005649
        label: appendicitis
    evidence:
      - reference: PMID:33402156
        supports: SUPPORT
        snippet: Repeat CT of the abdomen and pelvis with contrast (Fig. 1) was performed which showed progression of his colitis, now extending from the cecum to the rectum as well as findings concerning for appendicitis as seen on the prior CT scan. C. difficile testing was positive for which the patient was started on oral vancomycin.
        explanation: Case report documents appendicitis identified alongside CDI with CT progression guiding management.
datasets: []
environmental:
  - name: Healthcare facility exposure
    description: Hospital environments facilitate C. difficile spore persistence and transmission, underpinning healthcare-associated CDI.
    evidence:
      - reference: PMID:28613708
        supports: SUPPORT
        snippet: Contaminated surfaces and medical equipment in healthcare facilities can become reservoirs for C difficile spores, potentially transmitting to patients if proper cleaning protocols are not routinely implemented.
        explanation: Review notes hospital environmental reservoirs drive healthcare-associated CDI transmission.

</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Clostridioides_difficile_Infection.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
</body>
</html>